Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1258 | 8423 | 39.1 | 79% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
583 | 13291 | PHAGE DISPLAY//CATALYTIC ANTIBODIES//CATALYTIC ANTIBODY |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
1342 | 2612 | SCFV//SINGLE CHAIN FV//PHAGE DISPLAY |
5049 | 1614 | PHAGE DISPLAY//LANDSCAPE PHAGE//IN VIVO PHAGE DISPLAY |
7719 | 1257 | CATALYTIC ANTIBODY//CATALYTIC ANTIBODIES//ABZYMES |
9587 | 1074 | CANONICAL STRUCTURES//CDR CONFORMATION//ANTIBODY STRUCTURE |
13225 | 787 | PREDETERMINED SPECIFICITY//SYNTHETIC ANTIGENIC SITE//B CELL EPITOPE PREDICTION |
15976 | 613 | SINGLE DOMAIN ANTIBODY//NANOBODY//VHH |
25928 | 221 | DOMAIN INSERTION//PROTEIN SWITCH//BIFUNCTIONAL FUSION ENZYME |
29195 | 156 | SORBIN//NONCOMPETITIVE IMMUNOASSAY//PHAGE ANTI IMMUNOCOMPLEX ASSAY |
33550 | 89 | AFFINITY MASS SPECTROMETRY//PEPTIDE CHIP ANALYSIS//PROTEOLYTIC EPITOPE EXCISION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PHAGE DISPLAY | Author keyword | 500 | 39% | 12% | 997 |
2 | CATALYTIC ANTIBODIES | Author keyword | 211 | 77% | 2% | 145 |
3 | CATALYTIC ANTIBODY | Author keyword | 196 | 76% | 2% | 136 |
4 | ANTIBODY ENGINEERING | Author keyword | 132 | 48% | 2% | 204 |
5 | SCFV | Author keyword | 107 | 36% | 3% | 240 |
6 | ABZYMES | Author keyword | 104 | 90% | 1% | 45 |
7 | SINGLE CHAIN FV | Author keyword | 94 | 51% | 2% | 130 |
8 | SINGLE DOMAIN ANTIBODY | Author keyword | 90 | 71% | 1% | 73 |
9 | ABZYME | Author keyword | 89 | 84% | 1% | 48 |
10 | ANTIBODY LIBRARY | Author keyword | 78 | 70% | 1% | 64 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PHAGE DISPLAY | 500 | 39% | 12% | 997 | Search PHAGE+DISPLAY | Search PHAGE+DISPLAY |
2 | CATALYTIC ANTIBODIES | 211 | 77% | 2% | 145 | Search CATALYTIC+ANTIBODIES | Search CATALYTIC+ANTIBODIES |
3 | CATALYTIC ANTIBODY | 196 | 76% | 2% | 136 | Search CATALYTIC+ANTIBODY | Search CATALYTIC+ANTIBODY |
4 | ANTIBODY ENGINEERING | 132 | 48% | 2% | 204 | Search ANTIBODY+ENGINEERING | Search ANTIBODY+ENGINEERING |
5 | SCFV | 107 | 36% | 3% | 240 | Search SCFV | Search SCFV |
6 | ABZYMES | 104 | 90% | 1% | 45 | Search ABZYMES | Search ABZYMES |
7 | SINGLE CHAIN FV | 94 | 51% | 2% | 130 | Search SINGLE+CHAIN+FV | Search SINGLE+CHAIN+FV |
8 | SINGLE DOMAIN ANTIBODY | 90 | 71% | 1% | 73 | Search SINGLE+DOMAIN+ANTIBODY | Search SINGLE+DOMAIN+ANTIBODY |
9 | ABZYME | 89 | 84% | 1% | 48 | Search ABZYME | Search ABZYME |
10 | ANTIBODY LIBRARY | 78 | 70% | 1% | 64 | Search ANTIBODY+LIBRARY | Search ANTIBODY+LIBRARY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FILAMENTOUS PHAGE | 345 | 55% | 5% | 429 |
2 | VARIABLE DOMAINS | 204 | 56% | 3% | 249 |
3 | HEAVY CHAIN ANTIBODIES | 191 | 73% | 2% | 147 |
4 | BY PASSING IMMUNIZATION | 186 | 77% | 2% | 128 |
5 | CATALYTIC ANTIBODIES | 176 | 54% | 3% | 224 |
6 | PHAGE DISPLAY | 167 | 26% | 7% | 559 |
7 | HYPERVARIABLE REGIONS | 146 | 48% | 3% | 225 |
8 | IMMUNOGLOBULIN VARIABLE DOMAINS | 143 | 77% | 1% | 96 |
9 | SINGLE CHAIN FV | 139 | 38% | 3% | 291 |
10 | HEALTHY HUMAN MOTHERS | 128 | 94% | 1% | 46 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IMMUNOTECHNOLOGY | 24 | 44% | 0% | 42 |
2 | PROTEIN ENGINEERING DESIGN & SELECTION | 11 | 11% | 1% | 100 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Nanobodies: Natural Single-Domain Antibodies | 2013 | 111 | 147 | 78% |
Nanobody-based products as research and diagnostic tools | 2014 | 24 | 82 | 73% |
Properties, production, and applications of camelid single-domain antibody fragments | 2007 | 201 | 85 | 86% |
Phage display | 1997 | 782 | 198 | 65% |
Selecting and screening recombinant antibody libraries | 2005 | 447 | 158 | 66% |
Engineered antibody fragments and the rise of single domains | 2005 | 708 | 120 | 39% |
MAKING ANTIBODIES BY PHAGE DISPLAY TECHNOLOGY | 1994 | 988 | 97 | 69% |
Potent antibody therapeutics by design | 2006 | 525 | 134 | 35% |
Single domain antibodies: promising experimental and therapeutic tools in infection and immunity | 2009 | 123 | 119 | 63% |
Bacteriophages as Scaffolds for Bipartite Display: Designing Swiss Army Knives on a Nanoscale | 2015 | 1 | 77 | 73% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHEM IMMUNOL THER EUT | 32 | 85% | 0.2% | 17 |
2 | IG THER Y CO | 23 | 100% | 0.1% | 10 |
3 | MINIST PUBL HLTH RUSSIAN FEDERAT | 13 | 69% | 0.1% | 11 |
4 | LIFE SCI BIOMOL ENGN | 12 | 59% | 0.2% | 13 |
5 | CELLULAIRE MOL IMMUNOL | 10 | 73% | 0.1% | 8 |
6 | ABT BIOTECHNOL | 9 | 45% | 0.2% | 15 |
7 | GDR2352 | 9 | 83% | 0.1% | 5 |
8 | COMBINATORIAL BIOL UNIT | 8 | 100% | 0.1% | 5 |
9 | RIC FARMACOL | 8 | 100% | 0.1% | 5 |
10 | STRUCT MECHANIST ENZYMOL | 8 | 62% | 0.1% | 8 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000020129 | RADIOIMMUNOTHERAPY//BISPECIFIC ANTIBODIES//EP CAM |
2 | 0.0000013031 | CELL FREE PROTEIN SYNTHESIS//MEMBRANE PROTEIN//RIBOSOME DISPLAY |
3 | 0.0000010962 | RADIOISOTOPE SERV//GELATIN PARTICLE AGGLUTINATION//ANTIGEN ANTIBODY BINDING KINETICS |
4 | 0.0000010861 | HYDANTOINASE//D HYDANTOINASE//DIRECTED EVOLUTION |
5 | 0.0000010621 | REG PROTEIN//PANCREATITIS ASSOCIATED PROTEIN//NEURONAL THREAD PROTEIN |
6 | 0.0000010087 | FCRN//NEONATAL FC RECEPTOR//FC GAMMA RECEPTORS |
7 | 0.0000009412 | SOMATIC HYPERMUTATION//VDJ RECOMBINATION//CLASS SWITCH RECOMBINATION |
8 | 0.0000008154 | SILICATEIN//BIO SILICA//BIOSILICIFICATION |
9 | 0.0000008135 | RIBOSOME INACTIVATING PROTEINS//RICIN//TRICHOSANTHIN |
10 | 0.0000008045 | JOURNAL OF BIOMOLECULAR SCREENING//ANTIBODY MICROARRAYS//PROTEIN MICROARRAY |